全文获取类型
收费全文 | 7665篇 |
免费 | 579篇 |
国内免费 | 34篇 |
专业分类
耳鼻咽喉 | 69篇 |
儿科学 | 117篇 |
妇产科学 | 176篇 |
基础医学 | 962篇 |
口腔科学 | 222篇 |
临床医学 | 807篇 |
内科学 | 1848篇 |
皮肤病学 | 147篇 |
神经病学 | 641篇 |
特种医学 | 678篇 |
外科学 | 1376篇 |
综合类 | 36篇 |
预防医学 | 232篇 |
眼科学 | 156篇 |
药学 | 348篇 |
中国医学 | 2篇 |
肿瘤学 | 461篇 |
出版年
2024年 | 12篇 |
2023年 | 105篇 |
2022年 | 188篇 |
2021年 | 332篇 |
2020年 | 201篇 |
2019年 | 294篇 |
2018年 | 321篇 |
2017年 | 236篇 |
2016年 | 263篇 |
2015年 | 315篇 |
2014年 | 415篇 |
2013年 | 411篇 |
2012年 | 627篇 |
2011年 | 631篇 |
2010年 | 378篇 |
2009年 | 365篇 |
2008年 | 454篇 |
2007年 | 428篇 |
2006年 | 348篇 |
2005年 | 310篇 |
2004年 | 256篇 |
2003年 | 246篇 |
2002年 | 181篇 |
2001年 | 99篇 |
2000年 | 79篇 |
1999年 | 97篇 |
1998年 | 33篇 |
1997年 | 41篇 |
1996年 | 28篇 |
1995年 | 18篇 |
1994年 | 13篇 |
1993年 | 15篇 |
1992年 | 32篇 |
1991年 | 31篇 |
1990年 | 25篇 |
1989年 | 21篇 |
1988年 | 26篇 |
1987年 | 31篇 |
1986年 | 26篇 |
1985年 | 25篇 |
1984年 | 15篇 |
1983年 | 15篇 |
1982年 | 12篇 |
1981年 | 13篇 |
1979年 | 23篇 |
1975年 | 12篇 |
1932年 | 13篇 |
1931年 | 8篇 |
1924年 | 12篇 |
1922年 | 8篇 |
排序方式: 共有8278条查询结果,搜索用时 15 毫秒
101.
102.
Anke Augspach Joachim H. List Philipp Wolf Heike Bielek Carsten Schwan Ursula Els?sser-Beile Klaus Aktories Gudula Schmidt 《Toxins》2013,5(11):2241-2257
Prostate cancer is the most common malignancy, accounting for about 25% of all incident cases among men in industrialized countries. The human androgen-dependent prostate cancer cell line LNCaP, which is derived from a metastatic lesion of human prostatic adenocarcinoma, is frequently used to study prostate cancer associated signaling pathways in vitro. Recently it was described that Rho GTPase activation in these cells leads to apoptotic responses. We used the bacterial toxins CNFy and CNF1, which specifically and directly activate Rho GTPases by deamidation of a single glutamine. We asked whether these Rho activators could induce apoptosis in LNCaP cells. Our results indicate that RhoA activation, induced by CNFy, does lead to intrinsic apoptosis of the cells. Analysis of the underlying signaling pathway reveals that apoptosis induction requires the activity of Rho kinase (ROCK) and myosin activation, an apoptotic pathway previously identified in cancer stem cells. 相似文献
103.
104.
Consensus statement on prevention and management of adverse effects following rejuvenation procedures with hyaluronic acid‐based fillers
下载免费PDF全文
![点击此处可从《Journal of the European Academy of Dermatology and Venereology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
W.G. Philipp‐Dormston D. Bergfeld B.M. Sommer G. Sattler S. Cotofana P. Snozzi U. Wollina K.P.J. Hoffmann C. Salavastru K. Fritz 《Journal of the European Academy of Dermatology and Venereology》2017,31(7):1088-1095
Facial fillers play an important role in the correction of facial changes associated with ageing. They offer quick treatments in the outpatient setting with minimal subsequent downtime that provide predictable, natural‐looking, long‐lasting results. Adverse reactions after hyaluronic acid injections tend to be mild or moderate and rather temporary. However, as with all injected or implanted biomaterials, severe adverse events can occur and patients must be fully informed of potential risks prior to undergoing treatment. A panel of experts from Germany (D), Austria (A) and Switzerland (CH) developed recommendations, and this study provides the ‘DACH Consensus Recommendations’ from this group specifically on the use of hyaluronic acid fillers. The aim is to help clinicians recognize potential risks and to provide guidance on how best to treat adverse events if they arise. Contraindications to hyaluronic acid fillers are also detailed, and ways to prevent adverse events occurring are discussed. Hyaluronic acid‐based products are claimed to be very close to an ideal tissue augmentation agent; nevertheless, profound medical, anatomical and product knowledge are of paramount importance to minimize the occurrence of adverse reactions. 相似文献
105.
Philipp Stiefel Stefan Mauerhofer Jana Schneider Katharina Maniura-Weber Urs Rosenberg Qun Ren 《Antimicrobial agents and chemotherapy》2016,60(6):3647-3652
Efficient removal of biofilms from medical devices is a big challenge in health care to avoid hospital-acquired infections, especially from delicate devices like flexible endoscopes, which cannot be reprocessed using harsh chemicals or high temperatures. Therefore, milder solutions such as enzymatic cleaners have to be used, which need to be carefully developed to ensure efficacious performance. In vitro biofilm in a 96-well-plate system was used to select and optimize the formulation of novel enzymatic cleaners. Removal of the biofilm was quantified by crystal violet staining, while the disinfecting properties were evaluated by a BacTiter-Glo assay. The biofilm removal efficacy of the selected cleaner was further tested by using European standard (EN) for endoscope cleaning EN ISO 15883, and removal of artificial blood soil was investigated by treating TOSI (Test Object Surgical Instrument) cleaning indicators. Using the process described here, a novel enzymatic endoscope cleaner was developed, which removed 95% of Staphylococcus aureus and 90% of Pseudomonas aeruginosa biofilms in the 96-well plate system. With a >99% reduction of CFU and a >90% reduction of extracellular polymeric substances, this cleaner enabled subsequent complete disinfection and fulfilled acceptance criteria of EN ISO 15883. Furthermore, it efficiently removed blood soil and significantly outperformed comparable commercial products. The cleaning performance was stable even after storage of the cleaner for 6 months. It was demonstrated that incorporation of appropriate enzymes into the cleaner enhanced performance significantly. 相似文献
106.
107.
108.
109.
110.